Biological cost of fluoroquinolone resistance in Escherichia coli implicated in polyclonal infection

Pathol Biol (Paris). 2007 Jul;55(6):288-91. doi: 10.1016/j.patbio.2006.06.006. Epub 2006 Aug 1.

Abstract

Polyclonal Escherichia coli strains were isolated in a transplanted patient who experienced successive septic shocks. Fluoroquinolone susceptible and resistant strains were corresponding to different PFGE fragment profiles. The gyrA S83L mutation was associated with a reduction in biological fitness. Resistant strain was selected by a long-term single use of ofloxacin.

Publication types

  • Case Reports

MeSH terms

  • Drug Resistance, Bacterial
  • Escherichia coli Infections / drug therapy*
  • Fatal Outcome
  • Fluoroquinolones / therapeutic use*
  • Humans
  • Kidney Failure, Chronic / surgery*
  • Kidney Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Surgical Wound Infection / microbiology*

Substances

  • Fluoroquinolones